Published in Drug Law Weekly, October 5th, 2004
The presentation, titled "Antisense Inhibition of cFLIP Promotes Transplant Acceptance by Sensitizing Responding T Cells to Undergo Activation Induced Apoptosis," was presented by AVI senior scientist Dan Mourich, PhD. The findings of the study indicate that specific transplant acceptance can be achieved using AVI's antisense approach and that a novel method for promoting transplant survival without long-term immunosuppressive therapy is...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.